Friday, October 22, 2021

Because of Blood Clots, FDA and CDC Recommend Pausing Johnson & Johnson COVID Vaccine

Johnson & Johnson Vaccine*As many Americans continue to get vaccinated on the daily basis, the #CDC and the #FDA have issued a joint statement where they are recommending a pause on the use of the Johnson & Johnson COVID-19 vaccine Janssen after six reported U.S. cases of a rare and severe type of blood clot in individuals.

In the statement, it was noted that all six cases of the rare and severe type of blood clots occurred in women from the ages of 18 and 48, and the symptoms occurred 6 to 13 days after they were given the vaccination. It was noted that the treatment for these specific blood clots is different from the usual treatments. On Wednesday, the CDC will be holding a meeting with the Advisory Committee on Immunization Practices (ACIP) to review the cases to further discuss the significance of each case.

In the statement, they continued to state, “FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution.”

MORE NEWS ON EURWEB: Usher: Strip Club Slams Reports That Singer Used Fake Money to Tip Dancers

 

View this post on Instagram

 

A post shared by The Shade Room (@theshaderoom)

YOU MAY LIKE

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

SEARCH

THE CULTURECALENDAR: WHAT'S NEW & BLACK ON TV


TRENDING